⌘K

Login Start Free

Home/Filings/4/0001662579-23-000098

4//SEC Filing

Siegel Jolie 4

Accession 0001662579-23-000098

CIK 0001662579other

View on SEC.gov Company Profile

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 7:22 PM ET

Size

5.3 KB

Accession

0001662579-23-000098

Insider Transaction Report

Form 4

Period: 2023-09-18

C4 Therapeutics, Inc.CCCC

Chief Legal Officer

Transactions

Award
Stock Option (Right to Buy)
2023-09-18+120,000→ 120,000 total
Exercise: $2.15Exp: 2033-09-17→ Common Stock (120,000 underlying)

Footnotes (1)

[F1]This option shall vest in full on September 18, 2025, subject to the Reporting Person's continued service on such date.

Documents

1 file

4
wk-form4_1695165751.xmlPrimary
FORM 4

Issuer

C4 Therapeutics, Inc.

CIK 0001662579

Entity typeother

Related Parties

1

filerCIK 0001768223

Filing Metadata

Form type: 4
Filed: Sep 18, 8:00 PM ET
Accepted: Sep 19, 7:22 PM ET
Size: 5.3 KB

View on SEC.gov